Cancer Care Ontario - Windsor Regional Cancer Centre

Windsor, Ontario N8W 2X3

0 studies enrolling now · 12 studies all time

What they study most

Bladder Cancer, Breast Cancer, Colorectal Cancer, Endometrial Cancer, Lung Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Ovarian Cancer, Pancreatic Cancer, Sarcoma, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer

Studies at this site

• Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma — Completed
• Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma — Completed
• ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer — Completed
• Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery — Completed
• Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer — Completed
• Combination Chemotherapy in Treating Patients With Multiple Myeloma — Completed
• Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma — Completed
• Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer — Completed
• Genetic Study in Patients With Stage II or Stage III Colon Cancer — Completed
• Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy — Completed
• Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer — Completed
• Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer — Completed